Product details
Background:Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.
• IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion., PMID:38941612
• Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development., PMID:39164066
• The Role of Interleukin-9 in Cancer., PMID:31016637
• IL-9, a local growth factor for synovial T cells in inflammatory arthritis., PMID:26751012
• Locus of (IL-9) control: IL9 epigenetic regulation in cellular function and human disease., PMID:38825637
• Interleukin-9 and mast cells., PMID:23034251
• IL-9 sensitizes human TH2 cells to proinflammatory IL-18 signals in atopic dermatitis., PMID:39521283
• IL-9 and IL-9-producing cells in tumor immunity., PMID:32228589
• Interleukin-9 and T helper type 9 cells in rheumatic diseases., PMID:27159882
• IL-9-producing T cells: potential players in allergy and cancer., PMID:32788707






